DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Nghiem P, Bhatia S, Lipson EJ. et al.
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
Journal of Clinical Oncology 2019;
37: 693-702
We do not assume any responsibility for the contents of the web pages of other providers.